Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidn...(ed nextyear by Simon and Schuster. The b...)

Date:12/7/2007

ed next year by Simon and Schuster. The book is a compilation of updated classics from her archive of family recipes using the best seasonal ingredients. Katie regularly appears on Extra as a special correspondent, covering everything from red carpet events to food to fashion. Katie is a contributing editor to Gotham magazine, and her culinary and lifestyle column, Katie's Kitchen, is published weekly in its sister magazine, Hamptons.

Katie was the first season host of Bravo's hit "Top Chef," a reality competition series for the culinary arts. In July 2005, with partner Aleishall Girard, Katie co-created the Web site http://www.oliveandpeach.com, a site dedicated to food and the importance of "conscious consumption." She resides in the New York area with her husband, musician Billy Joel.

FOSRENOL

FOSRENOL is indicated to reduce serum phosphate in patients with end stage renal disease (ESRD) -- also known as CKD Stage 5.

FOSRENOL is an effective, non-calcium, phosphate binder that reduces high phosphorus levels in ESRD patients. FOSRENOL is formulated as an easy-to-use, unflavored, chewable tablet that can be taken without water, an important consideration for ESRD patients who must restrict their fluid intake.

FOSRENOL is available in a broad range of dosage strengths consisting of 500-milligram (mg), 750-mg, and 1-g tablets. Patients taking FOSRENOL can achieve serum phosphorus target levels with as few as three tablets per day. (Dosing based on three meals per day. Number of meals per day may vary. To achieve certain doses, additional tablets may be required.)

FOSRENOL has a high affinity for phosphate and works by binding to dietary phosphorus in the gastrointestinal tract. Once bound, the FOSRENOL/phosphorus complex cannot pass into the bloodstream and is eliminated from the body, thereby decreasing mean serum phosphorus levels.

To date, FOSRENOL has been cl
'/>"/>

SOURCE Shire Pharmaceuticals Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
2. The next generation: nanomagnets could replace semiconductors
3. IBM and Imago find a crucial difficulty in semiconductor device scaling
4. Doping technique brings nanomechanical devices into the semiconductor world
5. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
6. NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
7. New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays
8. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML